Japan's health ministry has approved a cutting-edge treatment for blood cancer that uses a patient's own immune cells.
The domestic arm of Swiss pharmaceutical giant Novartis submitted the application for Kymriah.
This is the first cancer treatment involving CAR-T cell therapy to be approved in Japan.
The Lower House of Japan's Diet has approved a draft for a second supplementary budget for the current fiscal year.
The draft budget, totaling more than 27 billion dollars, includes funds to reinforce infrastructure such as river embankments and roads to enable them to withstand natural disasters. It also aims to make schools earthquake-resistant.
The Japanese government has approved a set of policy measures to make it easier for foreigners to live and work in Japan.
The package approved Tuesday is in line with a revised immigration law set to take effect in April marking a major policy change. Residential status now available only to high-skilled workers will become available to a much wider range of lower-skilled workers.
Japan's government has approved an application for a clinical test of treatment for an intractable blood disease using iPS cells, which can grow into any type of body tissue.
A health ministry panel on Friday gave the go-ahead to the application by a team at Kyoto University for the test for aplastic anemia.
Japanese authorities have laid down requirements for the production and sale of liquid baby formula, opening the door to the Japanese market.
This type of formula is easy to use because it doesn't require dissolving powder in hot water. It can also be stored at room temperature. It is widely available overseas but not in Japan, which lacks relevant safety regulations.